Comments
Loading...
Adagene (NASDAQ:ADAG) Stock Quotes, Forecast and News Summary
Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Adagene (ADAG) stock?
You can purchase shares of Adagene (NASDAQ:ADAG) through any online brokerage.
Who are Adagene (ADAG) competitors?
Other companies in Adagene’s space includes: Invizyne Technologies (NASDAQ:IZTC), Anixa Biosciences (NASDAQ:ANIX), Monopar Therapeutics (NASDAQ:MNPR), Inovio Pharmaceuticals (NASDAQ:INO) and Century Therapeutics (NASDAQ:IPSC).
What is the forecast, or price target, for Adagene (ADAG) stock?
Adagene has a consensus price target of $5.00.
What is the current price for Adagene (ADAG)?
The stock price for Adagene (NASDAQ: ADAG) is $2.36 last updated November 20, 2024 at 9:30 AM EST.
Does Adagene (ADAG) pay a dividend?
There are no upcoming dividends for Adagene.
When is Adagene (NASDAQ:ADAG) reporting earnings?
Adagene’s H1 earnings are confirmed for Thursday, July 25, 2024.
Is Adagene (ADAG) going to split?
There is no upcoming split for Adagene.
What sector and industry does Adagene (ADAG) operate in?
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.